The progressive supranuclear palsy (PSP) therapies market
Roots Analysis has announced the addition of “Progressive Supranuclear Palsy Therapies Market, 2021-2030” report to its list of offerings. Presently, there is no cure for PSP and the effectiveness of prescribed generic medications and non-drug therapies to improve the quality of life in patients, is limited. The high unmet patient need and rising caregiver […]
The progressive supranuclear palsy (PSP) therapies market Read More »